title: Adalimumab-induced psoriasis of the scalp with diffuse alopecia: a severe potentially irreversible cutaneous side effect of TNF-alpha blockers.
authors.forename: Laila
authors.initials: L
authors.lastname: El Shabrawi-Caelen
authors.forename: Michelangelo
authors.initials: M
authors.lastname: La Placa
authors.forename: Colombina
authors.initials: C
authors.lastname: Vincenzi
authors.forename: Thomas
authors.initials: T
authors.lastname: Haidn
authors.forename: Robert
authors.initials: R
authors.lastname: Muellegger
authors.forename: Antonella
authors.initials: A
authors.lastname: Tosti
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D011565:Psoriasis / Q000139:chemically induced*; D012536:Scalp Dermatoses / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab